Epidermal Langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 886-893

  Stoecklinger, Angelika ^a   Grieshuber, Ines ^a   Scheiblhofer, Sandra ^a   Weiss, Richard ^a   Ritter, Uwe ^b   Kissenpfennig, Adrien ^c   Malissen, Bernard ^d   Romani, Nikolaus ^e   Koch, Franz ^e   Ferreira, Fatima ^a   Thalhamer, Josef ^a   Hammerl, Peter ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d INSERM   (France)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DIPHTHERIA TOXIN RECEPTOR; DNA VACCINE; GAMMA INTERFERON; LANGERIN; OVALBUMIN; RECEPTOR; UNCLASSIFIED DRUG; CANCER VACCINE; CELL SURFACE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; GENE GUN IMMUNIZATION; HUMORAL IMMUNITY; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; MELANOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN CELL; TUMOR IMMUNITY; ANIMAL; BIOLISTIC TRANSFORMATION; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; EPIDERMIS; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODY FORMATION; BIOLISTICS; CANCER VACCINES; CELL PROLIFERATION; EPIDERMIS; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VACCINES, DNA;

EID: 34548803114     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.886     Document Type: Article

References (45)

1. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18: 927-974.
2. Donnelly, J. J., B. Wahren, and M. A. Liu. 2005. DNA vaccines: progress and challenges. J. Immunol. 175: 633-639.
3. Bivas-Benita, M., T. H. Ottenhoff, H. E. Junginger, and G. Borchard. 2005. Pulmonary DNA vaccination: concepts, possibilities and perspectives. J. Control Release 107: 1-29.
4. Cui, Z. 2005. DNA vaccine. Adv. Genet. 54: 257-289.
5. Choo, A. Y., D. K. Choo, J. J. Kim, and D. B. Weiner. 2005. DNA vaccination in immunotherapy of cancer. Cancer Treat. Res. 123: 137-156.
6. Lin, M. T., L. Pulkkinen, J. Uitto, and K. Yoon. 2000. The gene gun: current applications in cutaneous gene therapy. Int. J. Dermatol. 39: 161-170.
7. Romani, N., S. Holzmann, C. H. Tripp, F. Koch, and P. Stoitzner. 2003. Langerhans cells: dendritic cells of the epidermis. APMIS 111: 725-740.
8. Bauer, J., F. A. Bahmer, J. Worl, W. Neuhuber, G. Schuler, and M. Fartasch. 2001. A strikingly constant ratio exists between Langerhans cells and other epidermal cells in human skin: a stereologic study using the optical disector method and the confocal laser scanning microscope. J. Invest. Dermatol. 116: 313-318.
9. Bergstresser, P. R., C. R. Fletcher, and J. W. Streilein. 1980. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J. Invest. Dermatol. 74: 77-80.
10. Lenz, A., M. Heine, G. Schuler, and N. Romani. 1993. Human and murine dermis contain dendritic cells: isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92: 2587-2596.
11. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2: 1122-1128.
12. Garg, S., A. Oran, J. Wajchman, S. Sasaki, C. H. Maris, J. A. Kapp, and J. Jacob. 2003. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat. Immunol. 4: 907-912.
13. Larregina, A. T., S. C. Watkins, G. Erdos, L. A. Spencer, W. J. Storkus, D. Beer Stolz, and L. D. Falo, Jr. 2001. Direct transfection and activation of human cutaneous dendritic cells. Gene Ther. 8: 608-617.
14. + T cells after gene gun immunization. J. Exp. Med. 188: 1075-1082.
15. Morita, A., K. Ariizumi, R. Ritter III, J. V. Jester, T. Kumamoto, S. A. Johnston, and A. Takashima. 2001. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. Gene Ther. 8: 1729-1737.
16. Sudowe, S., I. Ludwig-Portugall, E. Montermann, R. Ross, and A. B. Reske-Kunz. 2006. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J. Allergy Clin. Immunol. 117: 196-203.
17. + T cell responses in gene gun DNA immunization. J. Immunol. 167: 5549-5557.
18. Hon, H., A. Oran, T. Brocker, and J. Jacob. 2005. B lymphocytes participate in cross-presentation of antigen following gene gun vaccination. J. Immunol. 174: 5233-5242.
19. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183.
20. Stoitzner, P., C. H. Tripp, A. Eberhart, K. M. Price, J. Y. Jung, L. Bursch, F. Ronchese, and N. Romani. 2006. Langerhans cells cross-present antigen derived from skin. Proc. Natl. Acad. Sci. USA 103: 7783-7788.
21. Valladeau, J., and S. Saeland. 2005. Cutaneous dendritic cells. Semin. Immunol. 17: 273-283.
22. Steele, K. E., K. Stabler, and L. VanderZanden. 2001. Cutaneous DNA vaccination against Ebola virus by particle bombardment: histopathology and alteration of CD3-positive dendritic epidermal cells. Vet. Pathol. 38: 203-215.
23. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576.
24. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhe, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
25. Juhlin, L., and W. B. Shelley. 1977. New staining techniques for the Langerhans cell. Acta Derm. Venereol. 57: 289-296.
26. Brtko, J., S. Mostbock, S. Scheiblhofer, A. Hartl, and J. Thalhamer. 1999. DNA immunization is associated with increased activity of type I iodothyronine 5′-deiodinase in mouse liver. Mol. Cell. Endocrinol. 152: 85-89.
27. Weiss, R., S. Scheiblhofer, J. Freund, F. Ferreira, I. Livey, and J. Thalhamer. 2002. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that overrules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20: 3148-3154.
28. Hochreiter, R., F. Ferreira, J. Thalhamer, and P. Hammerl. 2003. TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1. J. Allergy Clin. Immunol. 112: 579-584.
29. Hoffmann, A., S. Vieths, and D. Haustein. 1997. Biologic allergen assay for in vivo test allergens with an in vitro model of the murine type I reaction. J. Allergy Clin. Immunol. 99: 227-232.
30. Shastri, N., and F. Gonzalez. 1993. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J. Immunol. 150: 2724-2736.
31. Byers, A. M., C. C. Kemball, J. M. Moser, and A. E. Lukacher. 2003. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J. Immunol. 171: 17-21.
32. Schwarzler, C., G. Webersinke, R. Fassler, A. Lametschwandtner, H. Bauer, and H. C. Bauer. 1997. Incorporation of β-galactosidase-expressing endothelial cells into the skeletal muscle microvascular bed of mice. Cell Transplant. 6: 9-15.
33. Kissenpfennig, A., and B. Malissen. 2006. Langerhans cells: revisiting the paradigm using genetically engineered mice. Trends Immunol. 27: 132-139.
34. Klinman, D. M., J. M. G. Sechler, J. Conover, M. L. Gu, and A. S. Rosenberg. 1998. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J. Immunol. 160: 2388-2392.
35. Sudowe, S., I. Ludwig-Portugall, E. Montermann, R. Ross, and A. B. Reske-Kunz. 2003. Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses. Mol. Ther. 8: 567-575.
36. Chen, D., and L. G. Payne. 2002. Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res. 12: 97-104.
37. Kendall, M. 2005. Engineering of needle-free physical methods to target epidermal cells for DNA vaccination. Vaccine 24: 4651-4656.
38. Morita, A., and A. Takashima. 1998. Roles of Langerhans cells in genetic immunization. J. Dermatol. Sci. 20: 39-52.
39. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620.
40. + dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
41. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162.
42. + dendritic cells is sufficient for control of Leishmania major. J. Exp. Med. 199: 725-730.
43. Dupasquier, M., P. Stoitzner, A. van Oudenaren, N. Romani, and P. J. Leenen. 2004. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J. Invest. Dermatol. 123: 876-879.
44. Randolph, G. J., K. Inaba, D. F. Robbiani, R. M. Steinman, and W. A. Muller. 1999. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11: 753-761.
45. + antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J. Immunol. 176: 5730-5734.